PURPOSE: To evaluate the adverse effects (AEs) of antiepileptic drugs (AEDs) in adults with refractory epilepsy and their relationship with number of coprescribed AEDs and AED load. METHODS: Patients with refractory epilepsy were enrolled consecutively at 11 tertiary referral centers. AEs were assessed through unstructured interview and the Adverse Event Profile (AEP) questionnaire. AED loads were calculated as the sum of prescribed daily dose (PDD)/defined daily dose (DDD) ratios for each coprescribed AED. RESULTS: Of 809 patients enrolled, 709 had localization-related epilepsy and 627 were on polytherapy. AED loads increased with increasing number of AEDs in the treatment regimen, from 1.2 +/- 0.5 for patients on monotherapy to 2.5 +/- 1, 3.7 +/- 1.1, and 4.7 +/- 1.1 for those on two, three, and > or =4 AEDs, respectively. The number of spontaneously reported AEs correlated with the number of AEs identified by the AEP (r = 0.27, p < 0.0001). AEP scores did not differ between patients with monotherapy and patients with polytherapy (42.8 +/- 11.7 vs. 42.6 +/- 11.2), and there was no correlation between AEP scores and AED load (r = -0.05, p = 0.16). CONCLUSIONS: AEs did not differ between monotherapy and polytherapy patients, and did not correlate with AED load, possibly as a result of physicians' intervention in individualizing treatment regimens. Taking into account the limitations of a cross-sectional survey, these findings are consistent with the hypothesis that AEs are determined more by individual susceptibility, type of AEDs used, and physicians' skills, than number of coprescribed AEDs and AED load.
PURPOSE: To evaluate the adverse effects (AEs) of antiepileptic drugs (AEDs) in adults with refractory epilepsy and their relationship with number of coprescribed AEDs and AED load. METHODS:Patients with refractory epilepsy were enrolled consecutively at 11 tertiary referral centers. AEs were assessed through unstructured interview and the Adverse Event Profile (AEP) questionnaire. AED loads were calculated as the sum of prescribed daily dose (PDD)/defined daily dose (DDD) ratios for each coprescribed AED. RESULTS: Of 809 patients enrolled, 709 had localization-related epilepsy and 627 were on polytherapy. AED loads increased with increasing number of AEDs in the treatment regimen, from 1.2 +/- 0.5 for patients on monotherapy to 2.5 +/- 1, 3.7 +/- 1.1, and 4.7 +/- 1.1 for those on two, three, and > or =4 AEDs, respectively. The number of spontaneously reported AEs correlated with the number of AEs identified by the AEP (r = 0.27, p < 0.0001). AEP scores did not differ between patients with monotherapy and patients with polytherapy (42.8 +/- 11.7 vs. 42.6 +/- 11.2), and there was no correlation between AEP scores and AED load (r = -0.05, p = 0.16). CONCLUSIONS:AEs did not differ between monotherapy and polytherapy patients, and did not correlate with AED load, possibly as a result of physicians' intervention in individualizing treatment regimens. Taking into account the limitations of a cross-sectional survey, these findings are consistent with the hypothesis that AEs are determined more by individual susceptibility, type of AEDs used, and physicians' skills, than number of coprescribed AEDs and AED load.
Authors: Robert J Lamberts; Athanasios Gaitatzis; Josemir W Sander; Christian E Elger; Rainer Surges; Roland D Thijs Journal: Neurology Date: 2013-08-21 Impact factor: 9.910
Authors: Valentina Franco; Maria Paola Canevini; Giuseppe Capovilla; Giovambattista De Sarro; Carlo Andrea Galimberti; Giuliana Gatti; Renzo Guerrini; Angela La Neve; Eleonora Rosati; Luigi Maria Specchio; Salvatore Striano; Paolo Tinuper; Emilio Perucca Journal: CNS Drugs Date: 2014-10 Impact factor: 5.749
Authors: Maria Stella Vari; Francesca Pinto; Elisabetta Mencaroni; Giovanna Giudizioso; Carlo Minetti; Angela La Neve; Tiziana Francavilla; Marta Piccioli; Salvatore Striano; Luigi del Gaudio; Pierangelo Tovo; Pasquale Striano; Alberto Verrotti Journal: Clin Drug Investig Date: 2016-01 Impact factor: 2.859
Authors: Pablo Campo; Marta I Garrido; Rosalyn J Moran; Fernando Maestú; Irene García-Morales; Antonio Gil-Nagel; Francisco del Pozo; Raymond J Dolan; Karl J Friston Journal: Cereb Cortex Date: 2011-08-01 Impact factor: 5.357
Authors: E Manguoğlu; S Akdeniz; No Dündar; O Duman; B Aktekin; S Haspolat; U Bilge; D Ozel; G Lüleci Journal: Balkan J Med Genet Date: 2011-06 Impact factor: 0.519
Authors: Barbara Chmielewska; Krystyna Lis; Konrad Rejdak; Marcin Balcerzak; Barbara Steinborn Journal: Arch Med Sci Date: 2013-11-05 Impact factor: 3.318